Clene to Showcase Neurodegenerative Disease Research at Jones Las Vegas Technology and Innovation Conference

Clene Inc., a clinical-stage biopharmaceutical company specializing in neurodegenerative disease research, will participate in the upcoming Jones Las Vegas Technology and Innovation Conference on April 8-9, 2025. The conference, hosted at The Venetian Resort in Las Vegas, Nevada, represents a critical platform for the company to engage with institutional investors and showcase its groundbreaking work in treating conditions such as amyotrophic lateral sclerosis (ALS), Parkinson's disease, and multiple sclerosis.

The conference will provide a unique opportunity for Clene's leadership to connect directly with investors through one-on-one meetings, fireside chats, and panel discussions. Rob Etherington, CEO and President of Clene, emphasized the importance of these interactions, noting that the event allows the company to share its progress and engage in meaningful conversations with potential investors.

Organized by JonesTrading and supported by B2i Digital, Inc., the conference aims to create a collaborative environment where innovative companies can communicate their vision and potential impact. The event will feature keynote addresses from notable speakers, including Dr. Charity Dean, CEO of PHC Global, and Eric F. Trump, Executive Vice President of The Trump Organization.

Clene's participation highlights the company's commitment to advancing neurological disease treatments, particularly through its investigational therapy CNM-Au8®. This unique approach targets mitochondrial function and the NAD pathway while reducing oxidative stress, potentially offering new hope for patients suffering from debilitating neurological conditions.

The conference represents more than just an investor meeting; it serves as a critical platform for showcasing cutting-edge medical research and potential breakthrough treatments. By bringing together industry leaders, investors, and innovative companies, the Jones Las Vegas Technology and Innovation Conference plays a vital role in advancing medical research and potential therapeutic developments.